The ETS1 overexpression promotes malignancy through HGF/Met-mediated motility, which allows breast cancer cells to bypass the requirement of promigratory signals supplied by the environment (such as fibronectin) for invading (Furlan et al, 2008). This evidence concerns the gene HGF and breast cancer.